PROTECS Innovation Center in Blue Bell, which is owned by 4 Valley Square Group, has added two life science companies to its tenant roster, according to a staff report from The Pottstown Mercury.

KorGene, a market leader in developing targeted, molecular diagnostics, signed a lease on 8,259 square feet of the 50,000-square-foot lab and life sciences building. Meanwhile, ThirdLaw Technologies, which specializes in synthetic and computational chemistry, pharmaceuticals, biotechnology, biologics, and medical devices, will occupy 4,808 square feet.

“These two tenants were attracted to the existing lab infrastructure and required quick occupancy of the space, a trend we are seeing more of during the pandemic,” said Paul Touhey, CBRE senior vice president who represented the facility’s owners during the lease negotiations.

He added that the building has been dormant for nearly a decade “and by PROTECS applying their proven Innovation Center model to adaptively repurpose the building, it has been brought back to life in less than six months.”

Currently, 4 Valley Square Group is implementing several large-scale capital improvements on the property. These include modernizing interior common areas and updating the building façade, among other things.

Read more about PROTECS Innovation Center in Blue Bell at The Pottstown Mercury by clicking here.

You Might Also Like

Plymouth Meeting-Based Protecs Sets Its Sights on Developing New Building in Upper Merion

Upper Merion Approves over 500-home Toll Brothers King of Prussia Development

Myoderm Begins Development on New Headquarters, Warehouse Facility in Horsham